Serial Number 97331599
731

Registration Progress

Application Filed
Mar 25, 2022
Under Examination
Mar 26, 2024
Approved for Publication
Jan 30, 2024
Published for Opposition
Jan 30, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Sep 26, 2025 66 days

Trademark Image

Basic Information

Serial Number
97331599
Filing Date
March 25, 2022
Published for Opposition
January 30, 2024
Drawing Code
2

Status Summary

Current Status
Active
Status Code
731
Status Date
Mar 26, 2025
Application
Pending
Classes
035 036 041 042
+2 more

Rights Holder

The Board of Regents of the University of Texas System

14
Address
210 West 7th Street
Austin, TX 78701

Ownership History

The Board of Regents of the University of Texas System

Original Applicant
14
Austin, TX

The Board of Regents of the University of Texas System

Owner at Publication
14
Austin, TX

Legal Representation

Attorney
Robin Lightner Maisashvili

USPTO Deadlines

Next Deadline
66 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
September 26, 2025
Extension Available
Until March 26, 2025

Application History

31 events
Date Code Type Description Documents
May 5, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 27, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 27, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 26, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 26, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 25, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 25, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 25, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 25, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 26, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 30, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 30, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 10, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 28, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 4, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 4, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 4, 2023 ALIE A ASSIGNED TO LIE Loading...
Jun 29, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 3, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 3, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Apr 3, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 28, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 28, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 28, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 29, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 29, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 29, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 25, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 1, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 31, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 29, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
(Based on Intent to Use) Promoting collaboration within the scientific, research, pharmaceutical, and medical communities to achieve advances in healthcare, including to accelerate the development and use of immunotherapy in treatment of disease
Class 036
(Based on Use in Commerce) Charitable fundraising services
First Use Anywhere: Mar 24, 2022
First Use in Commerce: Mar 24, 2022
Class 041
(Based on Intent to Use) Educational services, namely, conducting programs, seminars, lectures and workshops in the fields of science and medicine relating to immunobiology, immunotherapy, wellness, cancer, diseases, and disease prevention and management; educational services, namely, developing and disseminating educational materials for others in the fields of science and medicine relating to immunobiology, immunotherapy, wellness, cancer, diseases, and disease prevention and management; arranging and conducting of training courses concerning research and development in the fields of cancer, autoimmune diseases, immunobiology and immunotherapy
Class 042
(Based on Use in Commerce) Medical research services; medical research, development, technical design, testing, and analysis services in the field of immunobiology, immunotherapy, antibodies, and oncology; consulting services in the fields of immunobiology, immunotherapy, antibodies, and oncology research, development, testing, analysis and data; medical research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; medical research services in the field of immune repertoire analysis and the genome; scientific research in the fields of immunobiology, immunotherapy, antibodies and oncology; biological research; laboratory research services in the fields of immunobiology, immunotherapy, antibodies, oncology, and cellular engineering; medical laboratory services; providing information on medical and scientific research in the field of immunobiology and immunotherapy; medical and scientific research for others in the field of stem cell research, cancer, immunobiology and immunotherapy; compiling data for research purposes in the field of medical science and medical consultancy; medical and scientific research liaison services, namely, consulting in the field of scientific research pertaining to clinical trials in the fields of health care, medicine, immunobiology, immunotherapy, pharmacology and biotechnology; collection and management of medical and scientific data for research purposes in the field of medical and scientific research; pharmaceutical research services; pharmaceutical research services relating to cancer
First Use Anywhere: Mar 24, 2022
First Use in Commerce: Mar 24, 2022
Class 044
(Based on Intent to Use) Medical services; Dispensing of pharmaceuticals; Medical and pharmaceutical consultation; Medical services relating to cancer; Dispensing of pharmaceuticals relating to cancer; immunobiology and immunotherapy medical services; medical services, namely, the treatment of cancer, disease management, disease prevention and early detection, standardized diagnosis, staging and treatment, care and care assessment, medical counseling; medical consulting services, namely, consulting on the treatment of cancer, disease management, disease prevention and early detection, standardized diagnosis, staging and treatment, care and care assessment, and patient care management; providing medical information; providing health information in the field of immunobiology, immunotherapy, oncology and diseases; providing a web site featuring medical information; providing a web site featuring health information in the field of immunobiology, immunotherapy, oncology and diseases; providing medical information, consultancy and advisory services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, medical diagnostic testing, monitoring and reporting services; providing information on health care via a telephone and the internet; providing information on cancer treatment; medical services, namely, treatment in the field of oncology and related health problems and diseases; providing medical information to patients and medical professionals in the field of immunotherapy and cancer treatment; medical analysis services, namely, analysis of tumors, cancer or equivalent medical conditions
Class 045
(Based on Intent to Use) Providing patient advocate services in the treatment of diseases and disorders utilizing immunotherapy

Additional Information

Design Mark
The mark consists of a solid red circle with a solid dark grey square intersecting it at the upper left corner, a solid light grey square intersecting it at the upper right corner, and a dark grey square outline intersecting it at the lower right corner, and in the background, a red square outline surrounds the red circle and light grey square with the solid dark grey square and dark grey square outline extending beyond the borders of the red square outline. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark.
Color Claim
The color(s) red and grey is/are claimed as a feature of the mark.

Classification

International Classes
035 036 041 042 044 045